NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









DeepLife

DeepLife

Private
ParisHealthcare & Life Scienceshttps://www.deeplife.co/

Last Round

Series A

Dec 10, 2024

Total Funding Raised

$15.87M

Company Overview

DeepLife is a biotechnology company that develops an AI-powered SaaS platform using digital twins of cells to accelerate drug discovery, target identification, and cell engineering for pharmaceutical and biotech partners.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Revenue Share, Data as a Service

AI Layer

Application

Keywords

cellular digital twinAI drug discoveryin-silico simulationtarget identificationdrug repositioningtechbiogenerative AIcomputational biologycausal AIdigital biologygenerative biologybiotech SaaSmulti-omics dataautoimmune diseaseneurodegenerative disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DeepLife Comps

Public and private peers based on sector, stage, and business model.

DeepLife comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DeepLife Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 10, 2024
SeedAug 3, 2022

Key People

Founding team and executive leadership

Jonathan Baptista

Co-founder & CEO

Founding Team

DeepLife Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 8, 2025

    Monthly visitors grew 303% MoM, reaching 1.9K.

  • Nov 15, 2025

    Grew 19% QoQ, from 31 to 37 employees.

DeepLife Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DeepLife Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DeepLife's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range31
Year Founded2019
Last FundingDec 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.